A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

A recent study found that only 15% of cancer survivors discussed trials with their healthcare providers, with ...

Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...

A new campaign at UCC aims to make health research more inclusive, to include under-served groups like women, ethnic ...

Artificial Intelligence (AI) is no longer just a buzzword it is transforming the way healthcare is delivered and its influence is now reaching deep into the world of clinical trials from predicting ...

The way we study new medicines and treatments is changing quickly. One of the biggest reasons for this change is the use of ...

Researchers reviewing nearly 300 top-tier ADHD drug trials found that half skipped the rigorous, expert-led evaluations ...

A patient shares how an event about clinical trials at Moores Cancer Center brought a community together to educate and ...

Dr. Michael Serzan explains the importance of clinical trial enrollment for patients with kidney cancer and highlighted findings from the STELLA-002 trial.

This precision in risk prediction allows for targeted interventions, potentially reducing unnecessary treatments and improving clinical outcomes.

Northwestern University hasn’t received any funding from the NIH since the end of March. Not only could patients potentially stop receiving treatments that trials provided, the research itself could ...